Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
News > Health News
Audio By Carbonatix
3:01 PM on Wednesday, October 22
The Associated Press
SAN DIEGO--(BUSINESS WIRE)--Oct 22, 2025--
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET.
To participate in the conference call by telephone, dial (800) 579-2543 or (785) 424-1789 and reference Maravai LifeSciences, Conference ID: MARAVAI. The call will also be available via live or archived webcast on the "Investors" section of the Maravai web site at https://investors.maravai.com.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
View source version on businesswire.com:https://www.businesswire.com/news/home/20251022158643/en/
CONTACT: Contact Information:
Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: RESEARCH INFECTIOUS DISEASES GENETICS BIOTECHNOLOGY HEALTH PHARMACEUTICAL OTHER SCIENCE SCIENCE ONCOLOGY
SOURCE: Maravai LifeSciences, Inc.
Copyright Business Wire 2025.
PUB: 10/22/2025 04:01 PM/DISC: 10/22/2025 04:02 PM
http://www.businesswire.com/news/home/20251022158643/en
